Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.
Technology is transforming biotechnology and biopharmaceuticals, both in research and development and manufacturing.
By investing in biotechnology for pet food, we as entrepreneurs and business leaders can actually force the industry to change.
The volatile stock of Turning Point Therapeutics (NASDAQ: TPTX) is once again piquing the interest of high risk traders after the company announced encouraging data related to a pivotal trial....
Try your hand at morphing science and business for a great investment opportunity in biotech.
Biotech stocks are notoriously among the most volatile on the exchange which can be both a blessing and a curse. Hardest hit during market downturns, they can be the fastest...
It's arguably one of the more intriguing sectors of the market to look at right now based on a risk-to-reward basis. Let's take a look at 3 of the best biotech stocks to buy now.
This Former Banking Executive Wanted to Help a Friend Suffering From Lupus. Now He Leads a BioTech Company on the Verge of a Breakthrough COVID Treatment.
Inside the "why" of Brian Foster's move from finance to biotech.